Black renal transplant recipients have poorer long-term graft survival than CYP3A5 expressers from other ethnic groups

Nephrology Dialysis Transplantation

Volumn 25, Issue 2, 2010, Pages 628-634

  Ng, Fu Liang ^a,b   Holt, David W ^b   Chang, Rene W S ^b   MacPhee, Iain A M ^a,b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

CYP3A5; Ethnicity; Pharmacogenetics; Renal transplantation; Tacrolimus

Indexed keywords

CYTOCHROME P450 3A5;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNIC GROUP; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; UNITED KINGDOM;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CYTOCHROME P-450 CYP3A; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 75649127608     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp530     Document Type: Article

References (42)

1. Isaacs RB, Nock SL, Spencer CE et al. Racial disparities in renal transplant outcomes. Am J Kidney Dis 1999; 34: 706-712
2. Katznelson S, Gjertson DW, Cecka JM. The effect of race and ethnicity on kidney allograft outcome. Clin Transpl 1995; 379-394
3. Foster CE III, Philosophe B, Schweitzer EJ et al. A decade of experience with renal transplantation in African-Americans. Ann Surg 2002; 236: 794-804
4. Hariharan S, McBride MA, Cherikh WS et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62: 311-318
5. Goldfarb-Rumyantzev AS, Scandling JD, Pappas L et al. Prediction of 3-yr cadaveric graft survival based on pre-transplant variables in a large national dataset. Clin Transplant 2003; 17: 485-497
6. Mandal AK, Snyder JJ, Gilbertson DT et al. Does cadaveric donor renal transplantation ever provide better outcomes than live-donor renal transplantation? Transplantation 2003; 75: 494-500
7. Moore DE, Feurer ID, Rodgers S Jr et al. Is there racial disparity in outcomes after solid organ transplantation? Am J Surg 2004; 188: 571-574
8. Eckhoff DE, Young CJ, Gaston RS et al. Racial disparities in renal allograft survival: a public health issue? J Am Coll Surg 2007; 204: 894-902
9. Ishitani M, Isaacs R, Norwood V et al. Predictors of graft survival in pediatric living-related kidney transplant recipients. Transplantation 2000; 70: 288-292
10. Mitsnefes MM, Subat-Dezulovic M, Khoury PR et al. Increasing incidence of post-kidney transplant anemia in children. Am J Transplant 2005; 5: 1713-1718
11. Omoloja A, Mitsnefes M, Talley L et al. Racial differences in graft survival: a report from the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Clin J Am Soc Nephrol 2007; 2: 524-528
12. Morris PJ, Johnson RJ, Fuggle SV et al. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA). Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. Lancet 1999; 354: 1147-1152
13. Martins L, Fonseca I, Sousa S et al. The influence of HLA mismatches and immunosuppression on kidney graft survival: an analysis of more than 1300 patients. Transplant Proc 2007; 39: 2489-2493
14. Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation 2002; 74: 1377-1381
15. Kasiske BL, Anjum S, Shah R et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004; 43: 1071-1081
16. Kasiske BL, Snyder JJ, Gilbertson D et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-185
17. Vasquez EM, Benedetti E, Pollak R. Ethnic differences in clinical response to corticosteroid treatment of acute renal allograft rejection. Transplantation 2001; 71: 229-233
18. Pallet N, Thervet E, Alberti C et al. Kidney transplant in black recipients: are African Europeans different from African Americans? Am J Transplant 2005; 5: 2682-2687
19. Yeates K, Wiebe N, Gill J et al. Similar outcomes among black and white renal allograft recipients. J Am Soc Nephrol 2009; 20: 172-179
20. Kalil RS, Heim-Duthoy KL, Kasiske BL. Patients with a low income have reduced renal allograft survival. Am J Kidney Dis 1992; 20: 63-69
21. Press R, Carrasquillo O, Nickolas T et al. Race/ethnicity, poverty status, and renal transplant outcomes. Transplantation 2005; 80: 917-924
22. Butkus DE, Dottes AL, Meydrech EF et al. Effect of poverty and other socioeconomic variables on renal allograft survival. Transplantation 2001; 72: 261-266
23. Chakkera HA, O'Hare AM, Johansen KL et al. Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs. J Am Soc Nephrol 2005; 16: 269-277
24. Medina-Pestana JO, Sampaio EM, Vaz ML et al. Worse renal transplant outcomes observed among Afro-Brazilian patients on prospective registry data of 2461 renal transplants at least 1 year follow-up. Transplant Proc 2007; 39: 435-436
25. Rudge C, Johnson RJ, Fuggle SV et al. Renal transplantation in the United Kingdom for patients from ethnic minorities. Transplantation 2007; 83: 1169-1173
26. MacPhee IA, Fredericks S, Tai T et al. The influence of phar-macogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation. Am J Transplant 2004; 4: 914-919
27. Andrews PA, Sen M, Chang RWS. Racial variation in dosage requirements of tacrolimus. Lancet 1996; 348: 1446
28. Hesselink DA, van Schaik RH, van Agteren M et al. CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients. Pharmacogenet Ge-nomics 2008; 18: 339-348
29. Roy JN, Barama A, Poirier C et al. Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients. Pharmacogenet Genomics 2006; 16: 659-665
30. Kuypers DR, de Jonge H, Naesens M et al. CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients. Clin Pharmacol Ther 2007; 82: 711-725
31. Vadivel N, Garg A, Holt DW et al. Tacrolimus dose in black renal transplant recipients. Transplantation 2007; 83: 997-999
32. Fredericks S, Moreton M, Macphee IA et al. Genotyping cytochrome P450 3A5 using the Light Cycler. Ann Clin Biochem 2005; 42: 376-381
33. Levey AS, Bosch JP, Lewis JB et al. Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470
34. MacPhee IA, Fredericks S, Mohamed M et al. Tacrolimus phar-macogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians. Transplantation 2005; 79: 499-502
35. Michelon TF, Piovesan F, Pozza R et al. Noncompliance as a cause of renal graft loss. Transplant Proc 2002; 34: 2768-2770
36. Greenstein S, Siegal B. Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. Transplantation 1998; 66: 1718-1726
37. Opelz G, Dohler B. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 2005; 5: 2725-2731
38. Neylan JF. Racial Differences in renal transplantation after immuno-suppression with tacrolimus versus cyclosporine. Transplantation 1998; 65: 515-523
39. Cooper TY, Jordan CL, Willimon CM et al. Comparison of panel-reactive antibody levels in Caucasian and African American renal transplant candidates. Transplantation 1995; 60: 327-330
40. Hoffmann SC, Stanley EM, Cox ED et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2002; 2: 560-567
41. McDaniel DO, Barber WH, Nguyan C et al. Combined analysis of cytokine genotype polymorphism and the level of expression with al-lograft function in African-American renal transplant patients. Transpl Immunol 2003; 11: 107-119
42. Delaney NL, Esquenazi V, Lucas DP et al. TNF-alpha, TGF-beta, IL-10, IL-6, and INF-gamma alleles among African Americans and Cuban Americans. Report of the ASHI Minority Workshops: Part IV. Hum Immunol 2004; 65: 1413-1419